• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG ENITRA 8 HF-T QP; CRT-P

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG ENITRA 8 HF-T QP; CRT-P Back to Search Results
Model Number 407141
Device Problem Failure to Interrogate (1332)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/07/2023
Event Type  malfunction  
Event Description
It was reported that the device is not interrogable.The pacemaker was replaced.
 
Manufacturer Narrative
Implant date corrected from (b)(6) 2023 to (b)(6) 2018.The pacemaker was received for analysis.Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this pacemaker were re-investigated and all production steps were performed accordingly.Particularly the final acceptance test proved the device functions to be as specified.Upon receipt, the pacemaker was interrogated.The interrogation of the device was properly feasible and showed the eri battery status, confirming the clinical observation.The eri battery status was triggered on (b)(6) 2023.In addition, a warning message was displayed on the programming device as mentioned in the complaint description.The memory content of the device was thoroughly inspected.First, the amount of charge taken from the battery with respect to the battery state was verified, revealing the eri battery status to be normal and as expected.Further investigation of the available device data showed the detection of a left ventricular lead failure on (b)(6) 2023, leading to a left ventricular vector switch from lv1 tip - lv4 ring to lv1 tip - can and the automatic deactivation of capture control in the right ventricle.In addition, high left ventricular pacing output was noted of up to 3.0 v and 1.5 ms, which represents a high current consumption program, resulting in a faster battery discharge.In a next step, the ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.The current consumption was normal and as expected.In addition, the impedance measurement functions of the device were tested and proved to be fully functional.All measured impedances were normal and as expected.In conclusion, thorough analysis of the device and the available device data revealed no indication of a device malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENITRA 8 HF-T QP
Type of Device
CRT-P
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin 12359
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key18256999
MDR Text Key329612125
Report Number1028232-2023-06116
Device Sequence Number1
Product Code NKE
Combination Product (y/n)N
PMA/PMN Number
P070008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Model Number407141
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/06/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/21/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-